Lawrence A. Leiter
Brigham and Women's Hospital
2 papers in the Anchorcite directory, published between 2016 and 2018, cited 13,790 times in total.
ORCID profileResearch topics
- Diabetes Treatment and Management · 2 papers
- Heart Failure Treatment and Management · 2 papers
- Diabetes, Cardiovascular Risks, and Lipoproteins · 1 paper
- Chronic Kidney Disease and Diabetes · 1 paper
Frequent co-authors
- Steven P. Marso · 1 paper
- Stephen Charles Bain · 1 paper
- Agostino Consoli · 1 paper
- Freddy Goldberg Eliaschewitz · 1 paper
- Esteban Jódar · 1 paper
- Ildiko Lingvay · 1 paper
- Julio Rosenstock · 1 paper
- Jochen Seufert · 1 paper
Papers
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine · 2016 · 7,190 citations
BACKGROUND: Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor agonist semaglutide but are needed for oral semaglutide. METHODS: We assessed cardiovascular outcomes of…
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesNew England Journal of Medicine · 2018 · 6,600 citations
BACKGROUND: The cardiovascular safety profile of dapagliflozin, a selective inhibitor of sodium-glucose cotransporter 2 that promotes glucosuria in patients with type 2 diabetes, is undefined. METHODS: of body-surface area, new end-stage renal disease, or death from renal or cardiovascular causes)…
Metadata from OpenAlex (CC0).